Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 15Terminated 4Unknown 3

Sponsor Class

NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 3

Conditions

Kidney Neoplasms 4Carcinoma, Renal Cell 4Neoplasms, Plasma Cell 3Multiple Myeloma 3Lymphoma, Mantle-Cell 3Lymphoma 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia 3Rectal Neoplasms 2Pancreatic Neoplasms 2Melanoma 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Lymphocytic, Chronic, B-Cell 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Waldenstrom Macroglobulinemia 1Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cyclophosphamide 6fludarabine phosphate 5Busulfan 5Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Imatinib Mesylate 4Hydroxyurea 4Cytarabine 4Antilymphocyte Serum 4Radiotherapy 3Melphalan 3Interferon-alpha 3Dasatinib 3olverembatinib 2Tacrolimus 2Polymerase Chain Reaction 2Methylprednisolone 2Idarubicin 2Filgrastim 2Cyclosporine 2Cord Blood Stem Cell Transplantation 2sargramostim 1nilotinib 1inecalcitol 1flumatinib 1danusertib 1avelumab 1Whole-Body Irradiation 1Tyrosine Kinase Inhibitors 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Leukemia, Myeloid, Chronic-Phase × Interferon-alpha × Clear all
NCT00002869 2013-12-19

Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
800 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00025402 2013-12-18

Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
1,000 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00002771 2013-08-02

Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
750 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡